Fy19-Astar-Annual-Report.Pdf
Total Page:16
File Type:pdf, Size:1020Kb
CONTENTS About A*STAR 2 2 Our Mission and Vision OUR OUR 4 Message from the Chairman and CEO 5 Board Members MISSION VISION 6 Senior Management 7 Organisation Chart The Agency for Science, Technology and Research (A*STAR) A global leader in science, technology and open innovation. 8 Subsidiary Company drives mission-oriented research that advances scientific 8 Our Community discovery and technological innovation. We play a key role in A*STAR is a catalyst, enabler and convenor of significant nurturing and developing talent and leaders for our research research initiatives among the research community in Singapore Special Feature: institutes, the wider research community, and industry. and beyond. Through open innovation, we collaborate with Supporting Singapore’s Fight our partners in both the public and private sectors, and bring Our research creates economic growth and jobs for Singapore. science and technology to benefit the economy and society. Against COVID-19 As a Science and Technology Organisation, we bridge the gap 9 between academia and industry in terms of research and 11 Diagnostic Kits and development. In these endeavours, we seek to integrate the Complementary Systems relevant capabilities of our research institutes and collaborate 14 Antibody Discovery and Therapeutics with the wider research community as well as other public 15 Bioinformatics and Modelling Studies sector agencies towards meaningful and impactful outcomes. 16 Protective Face Masks 17 Analytics and Detection Together with the other public sector entities, we develop industry sectors by: integrating our capabilities to create impact with multi-national corporations and globally competitive Key Achievements companies; partnering local enterprises for productivity and 18 gearing them for growth; and nurturing R&D-driven start-ups by 19 Contributing to Better Health seeding for surprises and shaping for success. Outcomes for Singaporeans 22 Contributing to Societal Outcomes Our research, in addition, also contributes to societal 27 Contributing to the Transformation benefits such as improving outcomes in healthcare, urban of Singapore’s Economy living, and sustainability. These serve to enhance lives in 31 Talent for the Nation – Strengthening Singapore and beyond. a Vibrant Ecosystem for Research, Innovation, and Enterprise 40 Engaging the Community Annex: 43 Key Performance Indicators 2 ABOUT A*STAR 2 Our Mission and Vision 4 Message from the Chairman and CEO 5 Board Members 6 Senior Management 7 Organisation Chart 8 Subsidiary Company 8 Our Community MESSAGE FROM THE CHAIRMAN AND CEO The COVID-19 pandemic has greatly disrupted the global economy which have reinvented themselves, and pivoted into new markets societal and economic needs. To date, we have nurtured a pipeline and people’s lives. and new products to create good jobs. Our collaborations with the of 1,650 scholars who are actively contributing to the Research, large local enterprises are adding value to Singapore’s economy. Innovation & Enterprise (RIE) ecosystem in Singapore. A number of Singapore was able to respond decisively to the pandemic. Our In RIE 2020, A*STAR undertook about 2,000 projects with local them have become entrepreneurs, setting up their own start-ups R&D ecosystem has built deep capabilities in infectious diseases enterprises, and assisted over 420 companies with their operation following a successful research career at A*STAR. Others continue and antibody research, as well as artificial intelligence. A*STAR was and technology roadmapping. to drive innovation in the laboratories, and are recognised by the also able to contribute its expertise in diagnostics, modelling and global research community for their efforts. simulation, material science, and precision engineering. With our Equally important, A*STAR supports the mission of the public strong capabilities in intellectual property licensing and productisation sector across a broad range of areas, including healthcare, food The days ahead will see Singapore experience one of its most built over the years, A*STAR was able to help our local companies security, as well as smart cities and sustainability. Our goal is to difficult periods ever. A*STAR stands ready to support the develop new products and processes to combat this new coronavirus. improve life and living for Singapore and Singaporeans through nation in developing innovative solutions to secure better our science. health, societal and economic outcomes, and to contribute to Our scientists have also made important contributions to unravel the the furtherance of science. Together with our collaborators and mysteries of the SARS-CoV-2 virus that causes COVID-19, advancing A*STAR’s multi-pronged talent strategy builds a pipeline of skilled public sector partners, we will forge ahead with fortitude and community-based research globally. Collectively, our long-term R&D talent pool to drive innovation and contribute to the country’s resilience as Team Singapore. investment and capabilities have proven to be invaluable during these unprecedented times and helped A*STAR to respond rapidly in the war against the novel coronavirus. Along the way, we have enabled technology transfer to our local biotech and medtech companies, and allowed them to secure new export opportunities. In this year’s annual report, we dedicate a special section to the teams who have been working alongside public agencies and industry to combat the pandemic and help Singapore recover. With travel restrictions and other safety measures in place to curb the spread of the coronavirus, businesses must now adapt to the new rules of the game. A*STAR is committed to helping local enterprises survive, and even thrive, during these difficult times by embracing innovation. Ms Chan Lai Fung Mr Frederick Chew Chairman Chief Executive Officer Looking beyond these challenging times, we must be ready to capture new opportunities borne out of this crisis. Minister for Trade and Industry Chan Chun Sing said at the Quarterly Economic Survey (QES) 2Q 2020 press conference in August: “We are not returning to a pre-COVID world. We must chart a new path now”. In this report, beyond COVID-19, we showcase the impact of our industry partnerships through features of local start-ups and SMEs 4 BOARD MEMBERS (as at 31 March 2020) 1 Ms Chan Lai Fung 9 Mr Chng Kai Fong 19 Dr Omkaram Nalamasu Chairman Managing Director Senior Vice President and A*STAR Economic Development Board Chief Technology Officer Applied Materials 1 2 3 4 2 Mr Frederick Chew 10 Mr Anton S. Huber President Applied Ventures LLC Chief Executive Officer Former Chief Executive Officer A*STAR Digital Factory Division, Siemens AG 20 Professor Tan Eng Chye 3 Professor Barry Halliwell 11 Dr Benjamin Koh Khay Wee President National University of Singapore Chair Deputy Secretary (Development) Biomedical Research Advisory Council Ministry of Health A*STAR 21 Mr Yee Ping Yi Senior Advisor 12 Professor Lily Kong Deputy Secretary (Planning) Academic Appointments and Ministry of Finance President and Lee Kong Chian Research Excellence, Office of the 5 6 7 8 Chair Professor of Social Sciences Senior Deputy President and Provost Singapore Management University Tan Chin Tuan Centennial Professor National University of Singapore 13 Dr Josephine Kwa Director 4 Professor Sir John O’Reilly Barghest Building Performance Chair Science and Engineering Research 14 Mr Quek Gim Pew Advisory Council A*STAR Chief Defence Scientist Ministry of Defence Chairman 9 10 11 12 13 NICC (Standards) Ltd 15 Mr Ravinder Singh 5 Professor Isaac Ben-Israel President ST Engineering Electronics Ltd Chairman Israel Space Agency 16 Professor Subra Suresh 6 Professor Stefan Catsicas President Nanyang Technological University Science and Technology Strategy Singapore Advisor Nestlé S.A 14 15 16 17 17 Professor Sir Keith O’Nions 7 Professor William Chin Chair University of Nottingham, UK Executive Vice President Clinical and Translational Science Chair Frequency Therapeutics British Geological Survey, UK 8 Professor Chong Tow Chong 18 Mr Arunjai Mittal President and Acting Provost Independent Director Singapore University of Technology 18 19 20 21 and Design 5 SENIOR MANAGEMENT (as at 31 March 2020) 1 Mr Frederick Chew 8 Dr Peter Nagler Chief Executive Officer Chief Innovation Officer A*STAR A*STAR Executive Director 2 Professor Barry Halliwell Institute of Chemical & Engineering Sciences (ICES) Chair Biomedical Research Advisory Council A*STAR 9 Professor Ng Huck Hui 1 2 3 Senior Advisor to the President, Assistant Chief Executive NUS Biomedical Research Council * Tan Chin Tuan Centennial A STAR Professor 10 Professor Tan Sze Wee 3 Professor Sir John O’Reilly Assistant Chief Executive Chair Science and Engineering Research Council * Science and Engineering Advisory Council A STAR A*STAR Chairman 11 Mr Philip Lim NICC (Standards) Ltd Chief Executive Officer 4 5 6 Accelerate Technologies Pte Ltd 4 Mr Suresh Sachi Deputy Chief Executive (Corporate) 12 Professor Lisa F.P. Ng General Counsel Executive Director A*STAR A*STAR Graduate Academy (A*GA) Senior Principal Investigator 5 Professor Andy Hor Singapore Immunology Network (SIgN) Deputy Chief Executive (Research) A*STAR 7 8 9 6 Professor Sir David Lane Chief Scientist A*STAR 7 Professor Ong Yew Soon Chief Artificial Intelligence Scientist A*STAR President’s Chair Professor of Computer Science, NTU 10 11 12 6 ORGANISATION CHART (as at 31 March 2020) CORPORATE HUMAN RESOURCE FINANCE COMMUNICATIONS Group Director Group Director Group Director Ms